2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$6.33-$0.005 (-0.08%)
Price as of Jun 03, 2026 7:03 PM EDT- $756.3MMarket Cap
- 757.84%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$6.33-$0.005 (-0.08%)
RLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.33 | ||
Change | -$0.09 (-1.40%) | ||
Open | $6.41 | ||
High | $6.49 | ||
Low | $6.25 | ||
Previous Close | $6.42 | ||
Volume | 797,612 | ||
30-Day Average Volume | 963,586 | ||
1-Week Change | -12.81% | ||
1-Month Change | -17.15% | ||
1-Year Change | 757.84% | ||
3-Year Change | 123.67% | ||
5-Year Change | -79.16% | ||
Fundamentals | |||
Shares Outstanding | 104.9M | ||
Total Assets | $235.4M | ||
Market Cap | $756.3M | ||
Enterprise Value | $746.5M | ||
Period: QTR TTM FY | |||
Revenue | -$549,964.00 | ||
Net Income | -$19.1M | ||
Free Cash Flow | -$15.1M | ||
EBIT | -$19.1M | ||
EBITDA | -$19.1M | ||
Net Working Capital | $222.5M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | -1,357 | ||
P/B | 3 | ||
P/E | -33 | ||
PEG | -1 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 09/30/2019 | ||
Earnings & Revenue